Project Grant R03DE033779

Award Date 4/15/24
Completion Date 4/14/26
Dollars Obligated $762K
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
This Project Grant award, funded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $498,238 to investigate the oral microbiome and its association with oral mucositis and bloodstream infections in children undergoing hematopoietic cell transplants. The award supports a longitudinal study at Nationwide Children's Hospital to define changes in the oral microbial community and its relationship to...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $236,250 to the University of California, Los Angeles (UCLA) to investigate the relationship between adverse childhood experiences (ACEs), the oral microbiome, dental caries, and salivary biomarkers in children. The study aims to elucidate the potential biological mechanisms underlying ACE-associated dental caries...
This $157,500 Project Grant award, funded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), will support a one-year longitudinal study of the oral microbiome changes in HIV-exposed uninfected (HEU), HIV-positive, and HIV-unexposed uninfected children aged 3-4 years in Kisumu County, Kenya. The study will collect and analyze 1,080 oral swab samples from 360 children to compare the oral microbiome development...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $163,411.00 to The Ohio State University to study the interactions between Streptococcus mutans, a key driver of dental caries, and other commensal oral bacteria. The research aims to elucidate the nutritional niches and carbohydrate utilization preferences that allow these microbes to coexist within oral biofilms, with...
This Project Grant award of $483,000.00 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), supports the development of new statistical methods to analyze the causal effects of individual components within bundled interventions. The research seeks to address challenges in assessing the impacts of multi-component interventions, which are commonly used in dental clinical trials to increase statistical power....
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $164,255 to East Carolina University to develop and evaluate antimicrobial dental materials to inhibit dysbiotic biofilm formation associated with secondary caries. The key objectives are to: (1) synthesize a reverse amide 2-aminoimidazole derivative, H10, and generate a new methacrylate-based antimicrobial agent...
This $297,228 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), aims to develop new statistical methods and machine learning strategies to characterize the microbial basis of early childhood caries (ECC). The researchers at the University of North Carolina at Chapel Hill will conduct integrative analyses of metagenomics, metatranscriptomics, and metabolomics data from a...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $205,000 Project Grant under the Oral Diseases and Disorders Research Program (CFDA 93.121) to The Regents of the University of California, San Francisco (UCSF). The grant will fund research to investigate the relationship between the oral microbiome and adverse outcomes, such as bloodstream infections, in pediatric hematopoietic cell transplant recipients. The study aims to characterize the taxonomic and functional...
This $314,000 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support research to gain insights into the evolution of fungal resistance in the oral environment of HIV-positive individuals. The research will leverage an existing patient dataset to: 1) use long-read sequencing to profile the fungal mycobiome in patient saliva and caries samples, and 2) perform longitudinal...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), will provide $593,468 to the University of Pittsburgh to study the molecular mechanisms underlying dental caries susceptibility. Specifically, the research aims to (1) determine how the TRPS1 transcription factor regulates communication between developing odontoblasts and ameloblasts, and (2) identify genes and...

MICROBIOME ANALYSIS OF PLAQUE SAMPLES FROM A COMMUNITY-BASED SOCIO-BEHAVIORAL RCT TO REDUCE SUGARED FRUIT DRINKS IN ALASKA NATIVE CHILDREN - PROJECT SUMMARY/ABSTRACT DENTAL CARIES IS ONE OF THE MOST SIGNIFICANT PUBLIC HEALTH CHALLENGES IN ALASKA NATIVE COMMUNITIES. ADDED SUGARS FROM FRUIT DRINKS, ESPECIALLY KOOL-AID, ARE THE MAIN BEHAVIORAL RISK FACTOR FOR CARIES. OUR TEAM DEVELOPED AND IMPLEMENTED A COMMUNITY-BASED INTERVENTION TARGETING SUGARED FRUIT DRINKS IN ALASKA NATIVE CHILDREN (NIDCR GRANT NO. U01DE027629). THE SIX-MONTH INTERVENTION CONSISTED OF HEALTH EDUCATION DELIVERED BY A TRAINED INDIGENOUS COMMUNITY HEALTH WORKER, WHO TAUGHT FAMILIES ABOUT THE HARMS CAUSED BY SUGARED FRUIT DRINKS, INTRODUCED SUGAR-FREE ALTERNATIVES, AND PROVIDED PARENTS WITH SELF-EFFICACY TRAINING TO FACILITATE THE SWITCH. LOCAL STORES WERE RECRUITED TO SELL SUGAR- FREE KOOL-AID. WE ENROLLED 201 ALASKA NATIVE CHILDREN AGES 1 TO 10 YEARS; 143 CHILDREN IN TWO COMMUNITIES RECEIVED THE INTERVENTION AND 58 CHILDREN A THIRD COMMUNITY WERE IN THE DELAYED TREATMENT CONTROL GROUP. THE TRIAL ENDED IN MARCH 2023. OUR TEAM IS CURRENTLY EVALUATING THE INTERVENTION. THE MAIN TRIAL OUTCOME IS CHANGE IN ADDED SUGAR INTAKE FROM BASELINE TO 6M, MEASURED USING A VALIDATED HAIR BIOMARKER. THE TRIAL DID NOT INCLUDE A DISEASE OUTCOME, BUT WE COLLECTED SUPRAGINGIVAL PLAQUE SAMPLES FROM CHILDREN THROUGHOUT THE TRIAL (BASELINE, 1M, 3M, 6M) AND ARCHIVED THEM FOR FUTURE STUDY. WE NOW HAVE TRIBAL PERMISSIONS TO ANALYZE THE PLAQUE. THE GOAL OF THIS 2-YEAR R03 IS TO PROCESS AND ANALYZE THE 594 BANKED PLAQUE SAMPLES. THE AIMS ARE TO: (1) ASSESS THE RELATIONSHIP BETWEEN ADDED SUGAR INTAKE AND THE ORAL MICROBIOME IN ALASKA NATIVE CHILDREN; AND (2) CONDUCT MEDIATOR ANALYSES TO EXAMINE THE EFFECTS OF THE INTERVENTION ON THE MICROBIOME WITH ADDED SUGAR AS THE MEDIATOR. WE WILL TEST THE PRIMARY HYPOTHESIS THAT LOWER ADDED SUGAR INTAKE IS ASSOCIATED WITH INCREASED ALPHA DIVERSITY, WHICH IS A SIGNATURE OF A HEALTHY MICROBIOME. THE PROPOSED WORK WILL BE THE FIRST KNOWN STUDY TO EVALUATE HOW ADDED SUGAR IMPACTS THE MICROBIOME IN ALASKA NATIVE CHILDREN AND IS EXPECTED TO PROVIDE INSIGHT ON MECHANISMS OF THE ORIGINAL BEHAVIORAL TRIAL. THE KNOWLEDGE GAINED WILL BE CRITICAL IN REFINING FUTURE INTERVENTIONS AIMED AT REDUCING ADDED SUGAR INTAKE, PREVENTING CARIES, AND ADDRESSING ORAL HEALTH INEQUITIES THAT DISPROPORTIONATELY AFFECT INDIGENOUS COMMUNITIES.

Posted 4/2/24, 12:00 AM